UDG Healthcare PLC (LON:UDG) Rating Reaffirmed
Jefferies International now has a GBX 630.00 target on the 1.36 billion GBP market cap company or 14.35% upside potential. In an interesting research report revealed to investors on 15 December, UDG Healthcare PLC (LON:UDG) shares have had their “Buy” Rating has decided to restate by expert analysts at Jefferies International.
From a total of 6 analysts covering UDG Healthcare PLC (LON:UDG) stock, 4 rate it a ”Buy”, 0 a “Sell”, and 2 a ”Hold”. This means that 67% of the ratings are positive. The highest target price is GBX 9.31 while the lowest target price is GBX 5.86. The mean of all analyst targets is GBX 8.17 with a -26.78% below today’s (GBX 550.95) stock price. UDG Healthcare PLC was the topic of 12 analyst reports since July 31, 2015 according to the firm StockzIntelligence Inc. N+1 Singer maintained shares on November 24 with “Buy” rating. Davy Research maintained UDG stock in a recent report from November 19 with “Outperform” rating. Finally, Goodbody maintained the stock with “Buy” rating in a report issued on an August 6.
Approximately 538 shares of stock traded hands. Udg Healthcare PLC (LON:UDG) has risen 0.09% since May 18, 2015 and is uptrending. It has outperformed by 3.77% the S&P500.
UDG Healthcare plc is an Ireland-based well-known provider of services to healthcare industry. The company has a market cap of 1.36 billion GBP. The Firm is a well-known provider of outsourced commercialization solutions to healthcare companies. It has 44.61 P/E ratio. The Firm operates in three divisions: Ashfield Commercial & Medical Services, Supply Chain Services and Sharp Packaging Services.